Navigation Links
MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
Date:10/29/2010

potential treatment of migraine and has reported positive results from the efficacy portion of its Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking Statements In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate. Actual results may differ materially from current expectations based on risks and uncertainties affecting the Company's business, including, without limitation, risks and uncertainties relating to the conduct and completion of clinical trials, and relating to the preparation and filing of a New Drug Application and the regulatory process to have the Company's LEVADEX product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, available at http://edgar.sec.gov. CONTACTS:Nicole FoderaroWCG(415) 946-1058nfoderaro@wcgworld.com
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014 PuraMed BioScience®, Inc., (OTC ... (OTC) medicinal and healthcare products, announced it received the ... a hemp-based, advanced headache relief product, for planned distribution ... Colorado , Washington State ... With the MigraPure H Advanced headache relief gel formulation ...
(Date:12/24/2014)... , December 24, 2014 ... on Global Disposable Syringe Industry of 178 ... online business intelligence library. The ... Syringe Industry is a professional and deep ...  For overview analysis, the report introduces Disposable ...
(Date:12/24/2014)... , Dec. 23, 2014  The American ... blood pressure target for people with diabetes and ... or high doses of statins, in keeping with ... enacted by the American College of Cardiology (ACC) ... reflected in the most recent changes to the ...
Breaking Medicine Technology:PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4
(Date:12/24/2014)... 24, 2014 Verde Pointe Dental Associates 2014 ... "Last years homemade Christmas sweater lit up, but this ... 2014 winner is Tandy Wilson for the second year in ... says Kirk Kimmerling DDS. "She took pictures of the entire ... sweater." , "Every year I enjoy stopping by ...
(Date:12/24/2014)... “ Relax Melodies ” was featured on NewsWatch ... latest and coolest mobile applications on the iOS, Android, ... and host of NewsWatch, conducted the app review and ... they can fall asleep. , According to the National ... some sort of difficulty sleeping. Since that’s a huge ...
(Date:12/24/2014)... California (PRWEB) December 24, 2014 Final ... of the ProDenoise from Pixel Film Studios. , “The ProDenoise ... or grain in their footage,” said Christina Austin, CEO of ... in any Final Cut Pro X editors toolbox.” , Final ... noise or grain in their footage with ProDenoise from Pixel ...
(Date:12/24/2014)... Kathleen Doheny HealthDay Reporter ... diet of fast food might hurt your child in the ... fast food in fifth grade lagged behind by eighth grade, ... than 8,500 U.S. students. "The largest effects were found ... said study leader Kelly Purtell, assistant professor of human sciences ...
(Date:12/24/2014)... 2014 (HealthDay News) -- Longer and colder body cooling does ... brain damage from a lack of oxygen, a new study ... with this condition -- called hypoxic ischemic encephalopathy -- can ... Celsius (92.3 Fahrenheit) for 72 hours, experts say. Research ... of animals, so this study examined if the same would ...
Breaking Medicine News(10 mins):Health News:Verde Pointe Dental Associates Announces the 2014 Ugly Sweater Holiday Contest Winner 2Health News:An Application to Help with Insomnia was Featured on NewsWatch Television on December 19, 2014 2Health News:Pixel Film Studios released the ProDenoise plugin for Final Cut Pro X today. 2Health News:Can Fast Food Hinder Learning in Kids? 2Health News:Greater Cooling of Oxygen-Deprived Infants Fails to Improve Survival 2
... shows young donors experience a lower rate of adverse reactions ... , LAKE ZURICH, Ill., June 23 Fenwal Inc. ... Richard J. Benjamin, M.D., Ph.D., chief medical officer of the ... relative safety of automated two-unit red cell procedures and manual ...
... Healthcare, Inc. (PDHI) launches the ConXus Profile Third-Party Health ... merge historical data from third-party HRAs with data collected ... may be reluctant to switch their current HRA data ... health information accumulated over time. PDHI has developed ...
... say , TUESDAY, June 23 (HealthDay News) -- Women ... developing brain lesions, a new study has found. , Whether ... cognition, however, remains unknown, the researchers added. , "Migraine used ... occurred, but these data suggest that there may be tissue ...
... to maintain a healthy weight, , TUESDAY, June 23 (HealthDay ... increases the risk for pancreatic cancer, and obesity in middle ... new study finds. , Pancreatic cancer is the fourth leading ... United States. As the number of people who are overweight ...
... ... threaten financial and emotional health -- and your life, says cancer survivor Jo ... of health insurers. She thought the healthcare system might have changed since she ... serious condition. Godfrey knows she is not alone, and she is ...
... ... needs of our nation,s over-the-road drivers and will showcase their efforts at The Great West ... ... Lifeclinic International, Inc., the world,s leading manufacturer and distributor of automated blood pressure monitors ...
Cached Medicine News:Health News:Fenwal to Host Webinar on the Safety of 2-Unit Red Cell Collections From Young Donors 2Health News:Fenwal to Host Webinar on the Safety of 2-Unit Red Cell Collections From Young Donors 3Health News:PDHI Launches ConXus Profile Third-Party Health Risk Assessment Data-Load Process 2Health News:Migraine With Aura May Lead to Brain Lesions 2Health News:Migraine With Aura May Lead to Brain Lesions 3Health News:Obesity While Young Boosts Pancreatic Cancer Risk 2Health News:Obesity While Young Boosts Pancreatic Cancer Risk 3Health News:Insurance May Be Hazardous to Your Health: "They Figured It Was Cheaper to Kill Me" 2Health News:Insurance May Be Hazardous to Your Health: "They Figured It Was Cheaper to Kill Me" 3Health News:Insurance May Be Hazardous to Your Health: "They Figured It Was Cheaper to Kill Me" 4Health News:Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over-the-Road Professionals 2Health News:Lifeclinic Teams Up With Trucking Industry to Promote Health and Wellness to Over-the-Road Professionals 3
... detection and semi-quantitation of ... antigen in serum as ... diagnosis of autoimmune disease. ... performed either manually or ...
... for the detection and quantitation ... nuclear antigens (ENA) [RNP, Sm, ... in human serum. SS-A (Ro) ... in the diagnosis of SLE, ...
... Enzyme-linked immunosorbent assays for ... IgG antibodies to extractable nuclear ... human serum. SS-A (Ro) and ... the diagnosis of SLE, subacute ...
... Inc. ENA Screen ELISA test system is ... antibodies to extractable nuclear antigens (anti-ENA) in ... directional insert, this test system is capable ... such as those against Jo-1, Sm, Sm/RNP, ...
Medicine Products: